In an essay in Annals of INternal Medicine, dated 1/21/2025, two physicians can barely, after weeks of effort, get a key drug for their very sick child. The denials were repetitive and had to do with the exact verbiage on the FDA label.
https://www.acpjournals.org/doi/10.7326/ANNALS-24-02781
One connection I made would be when a specialty drug requires "XYZ" diagnostic test on the labeling, but an innovator lab has an LDT that provides superior performance, or a new generation of technology, but is not on-label.
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.